LiveBitcoin Holds Near $84K as ETF Outflows Raise Rally Concerns: markets liveFollow the coverage →
Skip to content
Share
News

INJ Price Rallies Over 20% as 21Shares Updates Injective ETF Filing

Follow The Market Periodical
INJ Price Rallies Over 20% as 21Shares Updates Injective ETF Filing

INJ price rose about 18% over 24 hours on Sept. 19 as Injective drew attention from two developments. 21Shares amended its proposed Injective ETF filing after INJ expanded natively onto Solana.

Injective traded near $6.88 in the latest CoinMarketCap reading. The token had already rallied after its Sept. 17 Solana rollout, making it difficult to attribute the move solely to the ETF amendment.

Injective Price Climbs as Trading Volume Expands

Injective price moved from about $5.98 to $7.60 during the 24 hours. The chart shows steady gains through most of the session, followed by a sharper move above $7.00. INJ crypto later traded near the upper end of the displayed range after briefly approaching $7.70. The token’s intraday move accelerated when price cleared $7.00, and volume stayed elevated.

Market activity rose alongside the price. CoinMarketCap showed a market capitalization near $759.8 million, up 23.8% over the same period. Injective’s 24-hour trading volume is near $281 million, up 194.4%. Its volume-to-market-cap ratio stood at 36.61%.

INJ Price 24-Hour Chart | Source: CMC
INJ Price 24-Hour Chart | Source: CMC

Supply data showed about 99.97 million INJ in circulation against a reported total supply of 100 million tokens. Fully diluted value stood near $760.05 million. Those figures place most of the reported token supply in circulation during the latest rally.

21Shares Updates Injective ETF Filing

21Shares filed an amended S-1 registration statement for its proposed Injective ETF on September 18. The amendment follows the original filing submitted on October 20, 2025. The proposed fund would seek exposure to INJ through a traditional exchange-traded structure. The filing itself does not authorize the product to begin trading.

The updated proposal targets a Nasdaq listing under the ticker TINJ. It also names the FTSE Injective Index as the pricing benchmark. The structure allows 21Shares to stake part of the fund’s INJ holdings and reflect staking rewards in the product. Reports on the amendment place the target staking range between 40% and 60%, subject to liquidity needs.

BNY Mellon is named as administrator, transfer agent, and cash custodian in the updated proposal. The original S-1 described 21Shares US LLC as the trust’s sponsor and planned direct INJ holdings.

Solana Launch Broadens Access to INJ

The price move also followed INJ’s launch on Solana as a native SPL token. The rollout added access through Solana-based trading and DeFi venues, including Jupiter, Raydium, Meteora, Pump.fun and DFlow. CoinMarketCap reported the Solana launch alongside the ETF amendment during the same trading period.

The two developments arrived as spot volume accelerated. However, the available market data do not separate buying linked to the Solana rollout from buying tied to the ETF filing. The timing only indicates that both events occurred during the broader rise in INJ’s price and trading volume.

INJ Price Prediction Targets $15.80 First

According to the latest INJ price prediction, INJ could move toward $15.80 if its current higher-low structure holds. The forecast identifies $15.80 as the first major resistance level. INJ would need to more than double from $7.60 to reach that zone.

INJ Price Prediction | Source: X
INJ Price Prediction | Source: X

A break above $15.80 could place $33.20 as the next level to watch. The price prediction then points to $47.16 as the next major target if INJ continues its upward structure.

The broader setup follows a sequence of higher lows after INJ recorded major cycle highs in 2021 and 2024.

This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency investments involve risk, and past performance does not guarantee future results. Readers should conduct their own research before making investment decisions.

Moses K
Written by
Moses KVerified

Moses K is a crypto journalist covering markets, regulation, and blockchain trends. He has written for The Coin Republic, Coinchapter, Cryptopolitan, Cryptotale, Coinspeaker, and MPost. Known for his concise, data-driven reporting, Moses focuses on price analysis, on-chain metrics, and policy developments shaping the global digital asset landscape.

NewsAnalysisCrypto News

About this article

PublishedSeptember 20, 2026 2:38 pm
Last updatedSeptember 20, 2026 2:08 pm
Written byMoses K
ReviewedFact-checked by the TMP editorial desk

This report follows our Editorial Policy, Fact-Checking Standards and Code of Ethics. Found an inaccuracy? See Corrections.

Disclaimer. Informational only, not financial advice. Crypto, forex and stocks are volatile, high-risk assets — always do your own research and consult a qualified adviser.

More in News

Advertisement Your banner here — reach 400K+ crypto, forex & stock investors Advertise → 728 × 90